Computers in Medicine Virtual Rehabilitation: Dream or Reality?

Berra, Kathy
August 2006
Clinical & Investigative Medicine;Aug2006, Vol. 29 Issue 4, p187
Academic Journal
The article reports on the important advances in the use of the Internet in the identification of persons at risk for a cardiovascular event and in the ability of the Internet to reduce the risk by providing interventions. Coronary heart disease is the number one cause of death for men and women in the United States.


Related Articles

  • The Copenhagen City Heart Study (Østerbroundersøgelsen). Aguib, Yasmine; Al Suwaidi, Jassim // Global Cardiology Science & Practice;2015, Vol. 2015 Issue 3, p1 

    The Copenhagen City Heart Study, also known as "Østerbroundersøgelsen", is a large prospective cardio-vascular population study of 20,000 women and men that was launched in 1975 by Dr Peter Schnohr and Dr Gorm Jensen together with statistician Jørgen Nyboe and Prof. A. Tybjærg...

  • New contract 'neglects' CHD primary prevention. Crawshaw, Simon // Pulse;10/4/2004, Vol. 64 Issue 39, p16 

    Reports that the contract in Great Britain neglects coronary heart disease (CHD) primary prevention in Great Britain. Reduction of risk factors for CHD.

  • A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology? Watts, Gerald F.; Sullivan, David R.; van Bockxmeer, Frank M.; Poplawski, Nicola; Hamilton-Craig, Ian; Clifton, Peter M.; O’Brien, Richard C.; Bishop, Warrick; George, Peter M.; Semsarian, Christopher; Tonkin, Andrew // Heart, Lung & Circulation;Sep2012, Vol. 21 Issue 9, p543 

    Familial hypercholesterolaemia (FH) is a co-dominantly inherited disorder that causes marked elevation in plasma cholesterol and premature coronary heart disease. There are at least 45,000 people with FH in Australia and New Zealand, but most remain undiagnosed and undertreated. To bridge this...

  • Avoiding Repeat Cardiac Events. Franklin, Barry A.; Shepherd, Roy J. // Physician & Sportsmedicine;Sep2000, Vol. 28 Issue 9, p31 

    Reveals that multifactorial risk-factor modification, especially intensive ways to manage hyperlipidemia, may prevent coronary artery disease. Risk reduction strategies published by the American Heart Association; Endorsement from the American College of Cardiology; Meaning of the abbreviation...

  • β-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure. Psaty, Bruce M.; Koepsell, Thomas D.; LoGerfo, James P.; Wagner, Edward H.; Inui, Thomas S. // JAMA: Journal of the American Medical Association;4/14/89, Vol. 261 Issue 14, p2067 

    Studies the use of beta-blockers in the prevention of coronary heart disease in patients with high blood pressure. Validity of cases' diagnoses; Indications for beta-blockers; Support for the hypothesis that beta-blockers can prevent incident events of nonfatal myocardial infarction in people...

  • The rewards of living right.  // Consumer Reports on Health;Oct94, Vol. 6 Issue 10, p118 

    Presents information on the role of controlling risk factors for coronary heart disease in life prolongation. Study findings.

  • Don't just sit there, do something.  // Consumer Reports on Health;Aug98, Vol. 10 Issue 8, p2 

    Focuses on some of the measures which can be used to reduce the risk of coronary heart disease, highlighting the report `How Much Exercise Fo You Really Need?' Identification of activities and lengths of time which persons can participate in these activities; When the report was released.

  • Cardiovascular risk reduction: What really works? Castelli, William P.; Ockene, Judith K. // Patient Care;5/30/1997, Vol. 31 Issue 10, p47 

    Examines preventive strategies against coronary heart disease. Epidemiological analysis of risk factors; Measures of heart disease risk reduction; Barriers to implementation of preventive services.

  • Lowering Cholesterol with Drugs and Diet. Pedersen, Terje R. // New England Journal of Medicine;11/16/95, Vol. 333 Issue 20, p1350 

    Editorial. Comments on an article in the November 16, 1995 issue of the `New England Journal of Medicine' which provides evidence of a substantial benefit from lowering cholesterol in men without signs of coronary heart disease. Study of the impact of pravastatin on cholesterol levels; Other...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics